Nuo Therapeutics

Nuo Therapeutics develops biological therapies to address the areas of wound care, inflammation and angiogenesis.

Nuo Therapeutics is a biotechnology company that develops, sells and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation and angiogenesis. The Company markets the AutoloGel System, a device for the production of platelet rich plasma (PRP) gel derived from the patient's own blood. The AutoloGel System is cleared by the United States Food and Drug Administration (FDA) for use on a variety of exuding wounds.